S&S Healthcare (4198) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 欣大健康

S&S Healthcare (4198) reported revenue of NT$19.4 million for Oct 2026, +26.3% year on year and -8.7% from the previous month. Revenue for Jan–Oct 2026 was NT$149.2 million (-10.0% year on year).

In Oct 2026, it ranked No. 127 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$30.4 million24/10Nov 2024 NT$14.7 millionDec 2024 NT$12.1 millionJan 2025 NT$14.6 millionFeb 2025 NT$13.9 million25/02Mar 2025 NT$38 millionApr 2025 NT$13.8 millionMay 2025 NT$15.9 millionJun 2025 NT$8.5 million25/06Jul 2025 NT$12.1 millionAug 2025 NT$15 millionSep 2025 NT$18.7 millionOct 2025 NT$15.3 million25/10Nov 2025 NT$14.5 millionDec 2025 NT$23.9 millionJan 2026 NT$15.3 millionFeb 2026 NT$11.9 million26/02Mar 2026 NT$13.1 millionApr 2026 NT$8.5 millionMay 2026 NT$7.8 millionJun 2026 NT$16.4 million26/06Jul 2026 NT$21.2 millionAug 2026 NT$14.6 millionSep 2026 NT$21.2 millionOct 2026 NT$19.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$19.4 million+26.3%-8.7%
Sep 2026NT$21.2 million+13.5%+45.7%
Aug 2026NT$14.6 million-3.2%-31.2%
Jul 2026NT$21.2 million+75.1%+29.4%
Jun 2026NT$16.4 million+92.3%+108.5%
May 2026NT$7.8 million-50.8%-7.3%
Apr 2026NT$8.5 million-38.5%-35.2%
Mar 2026NT$13.1 million-65.6%+10.1%
Feb 2026NT$11.9 million-14.5%-22.3%
Jan 2026NT$15.3 million+5.0%-36.0%
Dec 2025NT$23.9 million+97.4%+64.1%
Nov 2025NT$14.5 million-1.1%-5.2%
Oct 2025NT$15.3 million-49.5%-17.9%
Sep 2025NT$18.7 million+21.5%+24.3%
Aug 2025NT$15 million-40.1%+24.4%
Jul 2025NT$12.1 million-37.3%+42.1%
Jun 2025NT$8.5 million-55.1%-46.7%
May 2025NT$15.9 million-12.5%+15.7%
Apr 2025NT$13.8 million-19.4%-63.7%
Mar 2025NT$38 million+44.5%+173.4%
Feb 2025NT$13.9 million-52.9%-4.6%
Jan 2025NT$14.6 million-29.8%+20.4%
Dec 2024NT$12.1 million-44.5%-17.8%
Nov 2024NT$14.7 million-14.9%-51.6%
Oct 2024NT$30.4 million-25.3%+97.4%

Jan–Oct 2026 cumulative: NT$149.2 million (-10.0% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: S&S Healthcare vs PEC / S&S Healthcare vs Lotus Pharm / S&S Healthcare vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16